Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 1/20 | 0.54 |
| ▸ | CCR8 | P51685 | 1/20 | 0.54 |
| ▸ | METAP2 | P50579 | 1/20 | 0.43 |
| ▸ | TGFBR1 | P36897 | 10/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.40 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.38 |
| ▸ | NOS3 | P29474 | 1/20 | 0.36 |
| ▸ | NOS2 | P35228 | 1/20 | 0.36 |
| ▸ | BTK | Q06187 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12075530 | 0.86 | MEN1 (0.36) | CCR1CCR8BTK | |
| SCHEMBL12598652 | 0.84 | CCR1 (0.37) | CCR1CCR8BTK | |
| SCHEMBL12598648 | 0.84 | CCR1 (0.37) | CCR1CCR8BTK | |
| SCHEMBL30433661 | 0.78 | ASIC3 (0.46) | NOS3NOS2 | |
| SCHEMBL20557572 | 0.78 | ASIC3 (0.46) | NOS3NOS2 | |
| SCHEMBL19919698 | 0.77 | BTK (0.31) | TGFBR1BTK | |
| SCHEMBL29672802 | 0.77 | BTK (0.56) | TGFBR1BTK | |
| SCHEMBL15886669 | 0.77 | BTK (0.56) | TGFBR1BTK | |
| SCHEMBL16473174 | 0.74 | IDO1 (0.39) | — | |
| SCHEMBL12598659 | 0.73 | KDM4E (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110699063-B | Application of 6-methylpyridine tetrazole tetranuclear copper [ I ] complex in stimulus response luminescent and photochromic material | 江西理工大学 | 2022-08-05 | — | — | CN | disclosed |
| CN-110699063-A | Application of 6-methylpyridine tetrazole tetranuclear copper [ I ] complex in stimulus response luminescent and photochromic material | 江西理工大学 | 2020-01-17 | — | — | CN | disclosed |
| EP-2188620-B1 | COMPOUNDS USEFUL AS LIGANDS AND PARTICULARLY AS ORGANIC CHROMOPHORES FOR COMPLEXING LANTHANIDES AND APPLICATIONS THEREOF | COMMISSARIAT L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2017-08-23 | — | — | EP | disclosed |
| US-9040689-B2 | Compounds useful as ligands and particularly as organic chromophores for complexing lanthanides and applications thereof | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2015-05-26 | — | — | US | disclosed |
| US-9040689-B2 | Compounds useful as ligands and particularly as organic chromophores for complexing lanthanides and applications thereof | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2015-05-26 | — | — | US | disclosed |
| US-20120302607-A1 | C4-SUBSTITUTED ALPHA-KETO OXAZOLES | THE SCRIPPS RESEARCH INSTITUTE (US) | 2012-11-29 | — | — | US | disclosed |
| US-8183275-B2 | Substituted imidazoles as bombesin receptor subtype-3 modulators | MERCK SHARP & DOHME CORP. (US) | 2012-05-22 | — | — | US | disclosed |
| US-8183275-B2 | Substituted imidazoles as bombesin receptor subtype-3 modulators | MERCK SHARP & DOHME CORP. (US) | 2012-05-22 | — | — | US | disclosed |
| US-20110184026-A1 | C4-SUBSTITUTED ALPHA-KETO OXAZOLES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-07-28 | — | — | US | disclosed |
| US-20110112289-A1 | COMPOUNDS USEFUL AS LIGANDS AND PARTICULARLY AS ORGANIC CHROMOPHORES FOR COMPLEXING LANTHANIDES AND APPLICATIONS THEREOF | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2011-05-12 | — | — | US | disclosed |
| US-20110112289-A1 | COMPOUNDS USEFUL AS LIGANDS AND PARTICULARLY AS ORGANIC CHROMOPHORES FOR COMPLEXING LANTHANIDES AND APPLICATIONS THEREOF | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2011-05-12 | — | — | US | disclosed |
| US-20100204236-A1 | Substituted imidazoles as bombesin receptor subtype-3 modulators | MERCK SHARP & DOHME CORP. | 2010-08-12 | — | — | US | disclosed |
| US-20100204236-A1 | Substituted imidazoles as bombesin receptor subtype-3 modulators | MERCK SHARP & DOHME CORP. | 2010-08-12 | — | — | US | disclosed |
| WO-2009037277-A1 | COMPOUNDS USEFUL AS LIGANDS AND PARTICULARLY AS ORGANIC CHROMOPHORES FOR COMPLEXING LANTHANIDES AND APPLICATIONS THEREOF | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2009-03-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100204236-A1 | Substituted imidazoles as bombesin receptor subtype-3 modulators | BRS3, GPR119, GIPR | CCR1 3313/4885CCR8 2654/4885METAP2 2058/4885 |
| US-20120302607-A1 | C4-SUBSTITUTED ALPHA-KETO OXAZOLES | ACACA, AKR1C4, HSD17B12 | CCR1 335/4885CCR8 1465/4885METAP2 2384/4885 |
| US-20110112289-A1 | COMPOUNDS USEFUL AS LIGANDS AND PARTICULARLY AS ORGANIC CHROMOPHORES FOR COMPLEXING LANTHANIDES AND APPLICATIONS THEREOF | LAGE3, LOXL1, TBCB | CCR1 2063/4885CCR8 2534/4885METAP2 4032/4885 |
| US-20110184026-A1 | C4-SUBSTITUTED ALPHA-KETO OXAZOLES | ACACA, AKR1C4, HSD17B12 | CCR1 373/4885CCR8 1413/4885METAP2 2328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.